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Mathematical models of the TCA cycle derived previously for l4c tracer studies have been extended to 13C 
NMR to measure the 13C fractional enrichment of [2-i3C]acetyl-CoA entering the cycle and the relative ac- 
tivities of the oxidative versus anaplerotic pathways. The analysis is based upon the steady-state nrichment 
of i3C into the glutamate carbons. Hearts perfused with [2-Ylacetate show low but significant activity of 
the anaplerotic pathways. Activation of two different anaplerotic pathways is demonstrated by addition of 
unlabeled propionate or pyruvate to hearts perfused with [2-13C]acetate. In each case, the amount of 
[2-Wlacetate being oxidized and the relative carbon flux through anaplerotic versus oxidative pathways 
are evaluated. 
13-C NMR; Glutamate isotopomer; (Perfused heart) 
1. INTRODUCTION 
13C NMR spectroscopy is a powerful tool for 
measuring the contribution of competing 
metabolic pathways in intact cells and tissues 
[l-5]. It offers the distinct advantage over conven- 
tional 14C labeling methods in that the i3C enrich- 
ment at each carbon position in a molecule may be 
quantitated in intact tissue. A previous heart per- 
fusion study showed that the doublet/total intensi- 
ty ratio in the glutamate C4 resonance provides a 
direct measure of the fraction of acetyl-CoA de- 
rived from a particular i3C enriched oxidizable 
substrate [6]. This measurement assumes that the 
only carbon entering the TCA cycle is derived from 
the oxidizable substrate via acetyl-CoA. Although 
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this may be a reasonable assumption under some 
steady-state perfusion conditions, the technique is 
not appropriate under conditions where TCA cycle 
intermediates are being replenished via anaplerotic 
reactions. Such reactions include pyruvate carbox- 
ylation [7] and the pathways leading to net oxida- 
tion of amino acids or odd numbered fatty acids 
[8-lo]. Previous studies of acetate oxidation in the 
rat heart have shown that about 90% of the acetyl- 
CoA entering the TCA cycle is derived from this 
substrate [l l-131. Other studies have noted that 
the flux through anaplerotic pathways in glucose 
perfused hearts is about 8% of the citrate synthase 
flux [ 14,151. These approaches require measure- 
ment of the specific activity of [6-14C]citrate, the 
TCA cycle flux, and acetate utilization. We have 
applied models of the TCA cycle derived for 14C 
tracer studies [16-181 to the analysis of heart spec- 
tra obtained under steady-state 13C enrichment 
conditions. We report here a method for the deter- 
mination of carbon flux through the oxidative (net 
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oxidation of the acetyl group to CO2 and water) 
and anaplerotic pathways in intact, perfused rat 
hearts or heart extracts by r3C NMR spectroscopy. 
2. MATERIALS AND METHODS 
Standard reagents were obtained from Sigma. 
[2-13C]Acetate enriched to 99% was obtained from 
KOR Isotopes. Male Sprague-Dawley rats 
(300-350 g) were anesthetized with intraperitoneal 
pentobarbital and heparin (200 units) was injected 
intravenously about 1 min before the heart was ex- 
cised. The aorta was cannulated and the heart was 
perfused at 70 cm Hz0 with standard Krebs- 
Henseleit medium bubbled continuously with a 
95% Oz/Wo CO2 gas mixture. The heart and per- 
fusate temperatures were maintained at 37°C and 
the 02 tension at the level of the aorta cannula was 
>550 mmHg. The heart rate was monitored 
throughout the NMR experiment. 13C NMR spec- 
tra were obtained at 75.45 MHz as reported [6]. 
a bed e 
Intact heart spectra were collected in 5 min blocks 
(200 scans) until no further changes in the spectra 
were apparent. A final steady-state spectrum (1200 
scans) was then collected and the experimental 
parameters of interest were derived from this spec- 
trum as outlined in the text. The glutamate C3/C4 
ratio was corrected for small differences in nuclear 
Overhauser enhancement as follows: (C3/C4) cor- 
rected = 0.90 (C3/C4) observed. 
3. RESULTS AND DISCUSSION 
3.1. Effects of activation of an anaplerotic 
pathway on the “C NMR spectrum 
A high resolution, proton decoupled r3C NMR 
spectrum of a rat heart perfused to steady-state 
with [2-“Clacetate as its sole substrate is shown in 
the lower panel of fig. 1. This spectrum is similar to 
that reported [6] of a guinea pig heart perfused 
with [3-‘3C]lactate, showing high levels of 
glutamate and a single resonance from 
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Fig.1. r3C NMR spectra of a Langendorff perfused rat heart. After perfusion of the heart with 2.5 mM [2-13C]acetate 
for 30 min, the spectrum in the lower panel was obtained. Propionate (2.0 mM) was then added to the perfusate and 
after 40 min of re-equilibration, the spectrum in the upper panel was obtained. Peak assignments are: a, malate C2; 
b, glutamate C2; c, trimethylamino resonance of acetyl carnitine plus carnitine (natural abundance); d, aspartate C2; 
e, taurine (natural abundance); f, malate C3; g, aspartate C3; h, taurine (natural abundance); i, glutamate C4; j, 
glutamate C3; k, acetate C2; 1, methyl resonance of acetyl carnitine (“C enriched). A prominent resonance at 136 ppm 
(not shown) was also detected and assigned to fumarate C2,C3. 
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[2-13C]acetyl carnitine. [2-13C]Acetate was selected 
for these studies because this substrate insures that 
13C is entering the TCA cycle only via 
[2-13C]acetyl-CoA. Acetate perfusions also cor- 
respond to relatively low activity of the anaplerotic 
pathways in the heart [l 11. The upper panel of 
fig. 1 shows a r3C NMR spectrum of the same heart 
perfused to steady-state with [2-13C]acetate plus 
2 mM unlabeled propionate. Propionate was used 
as a co-substrate since it enters the TCA cycle only 
via an anaplerotic pathway, i.e., as succinyl-CoA. 
There are two major differences between these 
steady-state spectra. First, as expected [8], the en- 
try of unlabeled propionate into the TCA cycle 
significantly increases the concentration of all 4 
carbon TCA cycle intermediates (as reflected by 
the malate, aspartate and fumarate resonances) 
and decreases the steady-state levels of the 5 car- 
bon intermediate pools (as reflected by glutamate). 
Second, the 13C enrichment at the glutamate C2 or 
C3 positions relative to the glutamate C4 position 
has decreased in the acetate plus propionate perfu- 
sion, and the multiplet patterns due to spin-spin 
coupling have changed (see the glutamate C4 
resonance in the upper and lower panels, for 
example). 
3.2. Model of the TCA cycle 
Sophisticated mathematical models of the TCA 
cycle have been developed and validated to inter- 
pret i4C tracer results [ 16-181. These models may 
be readily extended to the analysis of r3C spectra 
of perfused hearts under steady-state conditions. 
The variables in the model developed for analysis 
of 13C spectra (fig.2) include: F,, the fraction of 
acetyl-CoA taking part in the citrate synthase reac- 
tion that is [2-13C]acetyl-CoA; a, the flux through 
all other TCA cycle intermediate pools (collectively 
called the anaplerotic reactions) expressed as a 
fraction of the citrate synthase flux, c; and the 
sizes of the 4, 5, and 6 carbon TCA cycle in- 
termediate pools. It was assumed that c and a 
would not change during the accumulation of a 
steady-state NMR spectrum, and, since the con- 
centration of TCA cycle intermediates are not 
changing in steady-state, the pathways for removal 
of carbon skeletons (i.e., via the malic enzyme [fl]) 
are as active as the pathways which replenish the 
intermediates. 
The model predicts that the metabolic 
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Fig.2. Model of the citric acid cycle for calculation of 
glutamate isotopomers. Flux through the anaplerotic 
pathways, a, is defined in our model as a fraction of the 
flux through citrate synthase, c. 
parameters of interest may be derived quite simply 
from two experimental parameters: 
glutamate C3/C4 = 1/(2y + 1) (1) 
glutamate C4 doublet/total = FJ(2y + 1) (2) 
where y = a/c. In comparison to 14C tracer studies 
[ 16-181, our Fc is equivalent o the specific activity 
of [2-14C]acetate after dilution with endogenous 
sources of acetate. The 4, 5 and 6 carbon in- 
termediate pool sizes influence the time required to 
reach steady-state labeling [5] but not the final 
glutamate spectrum. 
If the anaplerotic reactions are completely inac- 
tive (a/c = 0), 13C enrichment at glutamate C2, C3, 
and C4 is equal, and the doublet/total ratio at C4 
directly reports FE [2,6]. If anaplerotic reactions 
are active (a/c > 0), the 4 carbon TCA cycle pool 
is diluted with “C and this is reflected in a diminu- 
tion of the total r3C enrichment of glutamate at C2 
and C3 relative to C4. The C2 and C3 positions are 
always equally labeled in steady-state because of 
scrambling at these positions in the succinate and 
fumarate pools. 
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Table 1 
Fractional enrichment and flux data from 13C NMR spectra of perfused hearts 
Substrates NMR observation FE, fractional a/c, flux through 
13C enrichment of the combined ana- 
c3/c4 C4 doublet/total acetyl-CoA enter- plerotic reactions, 
ing the TCA cycle relative to flux 
through citrate 
synthase 
2.5 mM [Z13C]acetate 
(n = 4) 0.83 + 0.02 0.81 f 0.01 0.97 f 0.02 0.10 f 0.01 
2.5 mM [2-“Clacetate 
1.0 mM propionate 
(n = 4) 0.57 * 0.07 0.53 f 0.04 0.94 * 0.13 0.39 f 0.10 
2.5 mM [2-13C]acetate 
2.5 mM pyruvate 
(n = 4) 0.74 f 0.03 0.57 f 0.04 0.77 f 0.07 0.17 f 0.03 
2.5 mM [2-“Clacetate 
5.0 mM glucose 
5 U/l insulin (n = 7) 0.74 + 0.08 0.67 k 0.15 0.90 f 0.17 0.18 f 0.03 
These results (mean + SD) were derived from “C NMR spectra of the extracts of freeze clamped 
hearts as described in the text 
3.3. Analysis of 13C spectra to obtain quantitative 
- metabolic data 
We have measured the glutamate C3/C4 ratio 
and the glutamate C4 doublet/total ratio in hearts 
perfused with four different combinations of 
substrates. The source of 13C was in each case 
[2-13C]acetate. The results are presented in table 1. 
The data show that 90% or more of the acetyl- 
CoA entering the TCA cycle is derived from 
[2-13C]acetate in hearts perfused with acetate alone 
or with acetate plus propionate or glucose and in- 
sulin. Unlabeled pyruvate, however, effectively 
competes with [2-13C]acetate for entry into the cy- 
cle via pyruvate dehydrogenase and consequently 
Fc drops to 0.77. There is significant flow of 
unlabeled carbons through the TCA cycle pools 
(a/c = 0.10) when [2-13C]acetate is presented as the 
sole exogenous substrate. Addition of unlabeled 
pyruvate or unlabeled propionate increases the 
anaplerotic flux through two completely different 
pathways (i.e., pyruvate enters via pyruvate car- 
boxylase to form oxaloacetate while propionate 
carbons enter as succinyl-CoA), while the fraction 
of acetyl-CoA derived from acetate is reduced only 
by pyruvate. Glucose, even in the presence of in- 
sulin does not complete effectively with acetate for 
oxidation. 
3.4. Analysis of 13C spectra in the intact heart 
These principles may be applied to the analysis 
of 13C spectra obtained in the intact heart (fig.1). 
After correction for small Tr differences, the 
C3/C4 ratio was 0.80 under [2-13C]acetate perfu- 
sion and 0.48 under [2-13C]acetate plus propionate 
perfusion. Thus, a/c = 0.12 in the presence of 
acetate and increased to 0.54 when propionate 
(2 mM) was added to the perfusate. The fraction 
of acetyl-CoA derived from acetate was about 
90% under both conditions. The simplicity of this 
technique offers the possibility of measuring flux 
through multiple pathways in a single, intact heart 
under a variety of physiological, hormonal, and 
workload conditions. 
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